HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,943,203 | +0.4% | 699,656 | -10.7% | 0.06% | +14.5% |
| Q2 2023 | $80,619,590 | -13.5% | 783,856 | -8.3% | 0.06% | -14.1% |
| Q1 2023 | $93,244,414 | -7.9% | 854,356 | -4.0% | 0.06% | -12.3% |
| Q4 2022 | $101,231,473 | +72.8% | 889,556 | -6.0% | 0.07% | +73.8% |
| Q3 2022 | $58,577,000 | -21.3% | 946,468 | +1.4% | 0.04% | -16.0% |
| Q2 2022 | $74,437,000 | -24.2% | 933,268 | 0.0% | 0.05% | -9.1% |
| Q1 2022 | $98,189,000 | +11.7% | 933,268 | +14.4% | 0.06% | +3.8% |
| Q4 2021 | $87,896,000 | -5.0% | 815,668 | -3.4% | 0.05% | -10.2% |
| Q3 2021 | $92,514,000 | +13.8% | 844,568 | -2.7% | 0.06% | +18.0% |
| Q2 2021 | $81,277,000 | +4.0% | 867,968 | +2.3% | 0.05% | -3.8% |
| Q1 2021 | $78,120,000 | +28.3% | 848,756 | +2.0% | 0.05% | +20.9% |
| Q4 2020 | $60,865,000 | +88.6% | 832,056 | +100.3% | 0.04% | +72.0% |
| Q3 2020 | $32,273,000 | +36.8% | 415,456 | -2.1% | 0.02% | +25.0% |
| Q2 2020 | $23,591,000 | +119.2% | 424,456 | +16.8% | 0.02% | +81.8% |
| Q1 2020 | $10,760,000 | -16.7% | 363,256 | +1.8% | 0.01% | -15.4% |
| Q4 2019 | $12,922,000 | +36.4% | 356,956 | +2.6% | 0.01% | +30.0% |
| Q3 2019 | $9,472,000 | +24.7% | 347,856 | +10.2% | 0.01% | +25.0% |
| Q2 2019 | $7,595,000 | – | 315,656 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |